Professional Documents
Culture Documents
In terms of revenue, the hemodynamic monitoring systems market was valued at US$ 328.7
Mn in 2014 and is projected to reach US$ 508.4 Mn by 2021. Factors driving market growth
include government and private sector initiatives to reduce healthcare costs, rising
prevalence of lifestyle diseases, growing the geriatric patient population, increasing the
incidence of respiratory disorders and growing demand for the screening of critical
congenital heart disease (CCHD).
In terms of region, North America dominated the hemodynamic monitoring systems market
with over 30% share in terms of value in 2014 but is expected to lose its market share to
APAC by 2021. Europe accounted for over 20% of the total hemodynamic monitoring
systems market share in 2014 and will maintain its dominance through 2021. Among the
regions, APAC is projected to register the highest CAGR over 20152021 due to low-cost
product offerings by manufacturers in the region. As of 2014, APAC was the third-highest
contributor to the overall hemodynamic monitoring systems market, accounting for over
18% market share. By the end of 2021, it is projected to gain 330 BPS.
On the basis of device type, the market has been segmented into pulse contour,
oesophageal Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary
artery catheters.
The pulmonary artery catheters segment had a dominant share in the global hemodynamic
monitoring systems market in 2014, while the volume clamp segment accounted for over
20% share.
Global hemodynamic monitoring systems market is further segmented on the basis of end
use into hospitals, clinics, ambulatory surgery centres, home care settings and independent
catheterisation laboratories. Revenue contribution of the hospitals segment was over 40% in
2014 and is projected to increase to over 42% by 2021, registering a significant CAGR of
7.3%. Home care settings segment is anticipated to record highest CAGR during the forecast
period as hemodynamic monitoring systems are being adopted increasingly in home care
settings.
Key players in the global hemodynamic monitoring systems market include Edwards
Lifesciences Corporation, ICU Medical, Inc., Teleflex Incorporated, LiDCO Group Plc and
PULSION Medical Systems SE. Global players focus on research and development initiatives
for introducing innovative products to attain sustainable advantages over their competitors.
In addition, they also focus on expanding their regional presence through mergers and
acquisitions. In developed regions, hemodynamic monitoring systems manufacturers prefer
selling their products directly to the consumer. By contrast, most vendors in countries such
as China have tie-ups with suppliers to enhance their customer reach. Globally, medical
equipment manufacturers in China account for over 50% market share for exporting
noninvasive devices.
Market History:
The hemodynamic monitoring system is primarily used for clinical inspection of
cardiovascular health, longevity and quality of life of patients undergoing and recovering
from cardiac surgery. These parameters are measured using photometric, electrical,
pressure transducing equipment and invasive and noninvasive devices. The hemodynamic
monitoring system also involves a use of various intravascular catheters.
Some factors boosting the demand for hemodynamic monitoring systems are rising
prevalence of lifestyle diseases, increasing the incidence of respiratory disorders, growing
demand for the screening of critical congenital heart disease (CCHD), government and
private sector initiatives to reduce healthcare costs as well as growing geriatric patient
population.
CCHD, one of the seven most severe congenital heart defects, can be life threatening to
neonates. Asthma and chronic obstructive pulmonary diseases are among the most common
respiratory diseases. More than nine-tenths of deaths in low- and middle-income countries
occur due to chronic obstructive pulmonary diseases.
The global hemodynamic monitoring systems market has been segmented into devices
based on technologies and methods such as pulse contour, oesophageal doppler, volume
clamp, hemodynamic monitoring sensors and pulmonary artery catheters.
The pulmonary artery catheters segment is estimated to dominate the global hemodynamic
monitoring systems market with 35.0% share by 2015 end, followed by volume clamp
segment. Increasing concerns regarding use of invasive techniques, particularly pulmonary
artery catheter for measuring cardiac output, have paved way for alternative methods for
measuring hemodynamic variables. Cardiac surgeons are increasingly seeking less invasive
By application, the global hemodynamic monitoring systems market has been segmented
into invasive hemodynamic monitoring, non-invasive hemodynamic monitoring and
minimally invasive hemodynamic monitoring.
By end-use, the hemodynamic monitoring systems market is segmented into home care
settings, ambulatory surgery centres, hospitals, clinics and independent catheterisation
laboratories. Hospitals segment is projected to exhibit above-average growth during the
forecast period.
The global hemodynamic monitoring systems market has been segmented into five regions:
North America, Latin America, Europe, APAC and Middle East & Africa. North America region
was the largest market in terms of revenue contribution, accounting for 30.5% share of the
overall hemodynamic monitoring systems market in 2014. This is attributed to the
increasing number of cancer and cardiovascular patients, especially in the U.S. Europe
region is projected to lose 40 BPS during the forecast period. Among the five regions, APAC
region is projected to expand at the highest CAGR during the forecast period.
Some key players included in the report are Edwards Lifesciences Corporation, ICU Medical,
Inc., Teleflex Incorporated, LiDCO Group Plc and PULSION Medical Systems SE. Global players
are investing on R&D to introduce innovative products in order to gain competitive edge.
Additionally, they are also focusing on regional expansion through mergers and acquisitions.
In developed regions, hemodynamic monitoring systems manufacturers prefer selling their
products directly to consumer. By contrast, most vendors in countries such as China have
tie-ups with suppliers to enhance their customer reach. Globally, medical equipment
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com